Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3428]
News [7862]
Articles [63]
Editorials [9]
Conferences [212]
elearning [49]
ecancermedicalscience Editor's Choice for January 2014
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice for January 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
12 Feb 2014
Multiple Myeloma Debate 2014: Recent advances in multiple myeloma
Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios...
Multiple Myeloma Debate 2014: Recent advances in multiple myeloma ( Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios Dimopoulos )
2 Feb 2014
Critical insights on leukaemia and lymphoma from ASH 2013
Prof Robin Foa, Dr Simon Rule, Dr Clemens Wendtner
Critical insights on leukaemia and lymphoma from ASH 2013 ( Prof Robin Foa, Dr Simon Rule, Dr Clemens Wendtner )
2 Feb 2014
ALSYMPCA trial: Ra-223 effective and well-tolerated for CRPC with symptomatic...
Dr Sten Nilsson - Karolinska University Hospital, Stockholm, Sweden
ALSYMPCA trial: Ra-223 effective and well-tolerated for CRPC with symptomatic bone metastases ( Dr Sten Nilsson - Karolinska University Hospital, Stockholm, Sweden )
1 Feb 2014
Enzalutamide improves survival in men with metastatic castration-resistant...
Dr Tomasz M. Beer - Oregon Health & Science University, Portland, USA
Enzalutamide improves survival in men with metastatic castration-resistant prostate cancer ( Dr Tomasz M. Beer - Oregon Health & Science University, Portland, USA )
31 Jan 2014
Latest treatment for CRPC: Combinations, sequencing, radiotherapy and...
Dr Maria De Santis - Kaiser Franz Josef Hospital, Vienna, Austria
Latest treatment for CRPC: Combinations, sequencing, radiotherapy and immunotherapy ( Dr Maria De Santis - Kaiser Franz Josef Hospital, Vienna, Austria )
31 Jan 2014
Results of orteronel plus prednisone in the TAK-700 trial on mCRPC
Dr Robert Dreicer - Cleveland Clinic, Cleveland, USA
Results of orteronel plus prednisone in the TAK-700 trial on mCRPC ( Dr Robert Dreicer - Cleveland Clinic, Cleveland, USA )
31 Jan 2014
Advances in prostate cancer - a decade in review
Dr Karim Fizazi, Dr Cora Sternberg, Dr John Fitzpatrick, Dr Heather Payne, Dr...
Advances in prostate cancer - a decade in review ( Dr Karim Fizazi, Dr Cora Sternberg, Dr John Fitzpatrick, Dr Heather Payne, Dr Peter Nelson )
30 Jan 2014
Dissecting the biology of the androgen receptor pathway
Dr Peter Nelson - Fred Hutchinson Cancer Research Center, Seattle, USA
Dissecting the biology of the androgen receptor pathway ( Dr Peter Nelson - Fred Hutchinson Cancer Research Center, Seattle, USA )
30 Jan 2014
Prostate Cancer Debate 2014: Evolving treatment options in castration-resistant...
Dr Cora Sternberg, Dr Marc Rubin, Dr Heather Payne, Dr Maria De Santis and Dr...
Prostate Cancer Debate 2014: Evolving treatment options in castration-resistant prostate cancer ( Dr Cora Sternberg, Dr Marc Rubin, Dr Heather Payne, Dr Maria De Santis and Dr John Fitzpatrick )
27 Jan 2014
Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC)
Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin...
Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC) ( Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin, Ireland )
10 Jan 2014
mCRPC: Challenges and opportunities in a booming area
Dr Nicolas Mottet - University Hospital, Saint-Étienne, France
mCRPC: Challenges and opportunities in a booming area ( Dr Nicolas Mottet - University Hospital, Saint-Étienne, France )
10 Jan 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation